-
REAL WORLD SURVIVAL OUTCOMES FOLLOWING REIMBURSED ANTI-PD-1 IMMUNOTHERAPY FOR MELANOMA IN IRELAND A POPULATION-BASED NATIONAL CANCER REGISTRY STUDY
Aug 11, 2026, 17:16 PM -
CATEGORISATION AND PREVALENCE OF UNCERTAINTIES IN SERVICE DELIVERY AND IMPLEMENTATION COSTS IN NICE HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH PEDIATRIC PNEUMOCOCCAL DISEASE HOSPITALIZATIONS IN SPAIN: RESULTS FROM THE NATIONAL HOSPITAL DISCHARGE DATABASE
Aug 11, 2026, 17:16 PM -
UNDERSTANDING THE ECONOMIC IMPACT OF SURGICAL TREATMENT PATHWAYS IN RECTAL CANCER
Aug 11, 2026, 17:16 PM -
OBSERVED VERSUS FORECASTED UPTAKE OF NICE-RECOMMENDED OBESITY MEDICINES IN ENGLAND
Aug 11, 2026, 17:16 PM -
COST UTILITY ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE VERSUS FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL FOR MODERATE TO VERY SEVERE COPD: A COLOMBIAN PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION AND BUDGET IMPACT OF IMPLEMENTING TACE FOR HEPATOCELLULAR CARCINOMA IN BULGARIA
Aug 11, 2026, 17:16 PM -
REVIEW OF CLINICAL OUTCOME ASSESSMENTS (COA) IN DRUG APPROVALS 2024-25, INSIGHTS FROM FDA AND EMA LABELLING
Aug 11, 2026, 17:16 PM -
DISTINGUISHING VERIFICATION FROM JUDGMENT IN HUMAN-IN-THE-LOOP EVIDENCE SYNTHESIS
Aug 11, 2026, 17:16 PM -
ASSOCIATION BETWEEN EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY'S MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) AND SUBSIDY DECISIONS FOR THERAPIES IN SINGAPORE
Aug 11, 2026, 17:16 PM -
DOES EQ-HWB CAPTURE THE IMPACT OF CAREGIVING? A COMPARATIVE STUDY OF PERCEIVED COMPREHENSIVENESS AMONG CAREGIVERS AND NON-CAREGIVERS
Aug 11, 2026, 17:16 PM -
FISCAL IMPACT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES A GOVERNMENT EXPENDITURE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
PLATINUM-BASED ADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH RESECTED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
COST EFFECTIVENESS ENZALUTAMIDE VERSUS ABIRATERONE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: A MARKOV MODEL ANALYSIS FROM INDIAN HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REFINED ESTIMATES OF THE PERSISTENCE OF VACCINE EFFECTIVENESS INCREASE THE VALUE AND IMPACT OF 4CMENB ADOLESCENT VACCINATION
Aug 11, 2026, 17:16 PM -
ACCEPTANCE OF SURROGATE ENDPOINTS IN ONCOLOGY WITHIN EARLY BENEFIT ASSESSMENT IN GERMANY: AND YES, THERE ARE EXCEPTIONS
Aug 11, 2026, 17:16 PM -
HEALTH UTILITY AND WORK PRODUCTIVITY BURDEN ASSOCIATED WITH CO-OCCURRING ANXIETY AND CHRONIC PAIN AMONG ADULTS REPORTING DEPRESSION IN THE EU5
Aug 11, 2026, 17:16 PM -
RECONSTRUCTING TRIAL-SPECIFIC TIME-ZERO IN REAL-WORLD DATA: A GENETIC ALGORITHM APPROACH TO VALIDATE INDIGO TRIAL OUTCOMES
Aug 11, 2026, 17:16 PM -
VALUATION OF THE CARE PATHWAY BY THE TRANSPARENCY COMMITTEE (TC) (HAUTE AUTORITE DE SANTE): A RETROSPECTIVE REVIEW OF TC OPINIONS FROM JANUARY 2023 TO DECEMBER 2025
Aug 11, 2026, 17:16 PM -
THE VALUE OF ADDITIONAL FOLLOW-UP IN ONCOLOGY: A CASE STUDY OF HEALTH ECONOMIC ANALYSIS USING DANTE PHASE III TRIAL DATA COMBINED WITH ROUTINELY COLLECTED ELECTRONIC HEALTH RECORDS (HER)
Aug 11, 2026, 17:16 PM
